methionine has been researched along with Hypopharyngeal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, D; Babin, E; Bequignon, A; Chesnay, E; Constans, JM; Moreau, S; Regeasse, A; Sobrio, F | 1 |
| Boér, A; Emri, M; Esik, O; Herzog, H; Lengyel, E; Lengyel, Z; Liszkay, G; Repa, I; Sáfrány, G; Szakáll, S; Trón, L | 1 |
1 trial(s) available for methionine and Hypopharyngeal Cancer
| Article | Year |
|---|---|
Early response to chemotherapy in hypopharyngeal cancer: assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, Emission-Computed; Treatment Outcome | 2003 |
1 other study(ies) available for methionine and Hypopharyngeal Cancer
| Article | Year |
|---|---|
PET identifies transitional metabolic change in the spinal cord following a subthreshold dose of irradiation.
Topics: Butanols; Cell Survival; Dose-Response Relationship, Radiation; Female; Fibroblasts; Fluorodeoxyglucose F18; Humans; Hypopharyngeal Neoplasms; Methionine; Middle Aged; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Spinal Cord; Tomography, Emission-Computed | 2004 |